121 related articles for article (PubMed ID: 11129545)
1. [Cisapride does not modify prolonged Q-T interval in patients with liver cirrhosis].
Quera R; Madrid AM; Ugalde H; Defilippi C
Rev Med Chil; 2000 Aug; 128(8):847-52. PubMed ID: 11129545
[TBL] [Abstract][Full Text] [Related]
2. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
[TBL] [Abstract][Full Text] [Related]
3. Effect of cisapride on corrected QT interval in neonates.
Khorana M; Chankajorn W; Kanjanapattanakul W; Kirawittaya T; Horpaopan S; Chotigeat U; Sangtawesin W
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S590-5. PubMed ID: 14700153
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
[TBL] [Abstract][Full Text] [Related]
5. Effects of cisapride on abnormally prolonged endogastric alkalinity time and delayed gastric emptying in cirrhotic patients.
Pimpo MT; Frieri G; Saltarelli P; Ciccocioppo R; Aggio A; Marchetti G; Taddei G; Carlei F; Lygidakis NJ; Onori L
Hepatogastroenterology; 1996; 43(12):1678-84. PubMed ID: 8975988
[TBL] [Abstract][Full Text] [Related]
6. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors.
Bernardi M; Calandra S; Colantoni A; Trevisani F; Raimondo ML; Sica G; Schepis F; Mandini M; Simoni P; Contin M; Raimondo G
Hepatology; 1998 Jan; 27(1):28-34. PubMed ID: 9425913
[TBL] [Abstract][Full Text] [Related]
7. Effects of cisapride on ventricular repolarization in children.
Tutar HE; Kansu A; Kalayci AG; Girgin N; Atalay S; Imamoğlu A
Acta Paediatr; 2000 Jul; 89(7):820-3. PubMed ID: 10943965
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
Zambruni A; Trevisani F; Di Micoli A; Savelli F; Berzigotti A; Bracci E; Caraceni P; Domenicali M; Felline P; Zoli M; Bernardi M
J Hepatol; 2008 Mar; 48(3):415-21. PubMed ID: 18194821
[TBL] [Abstract][Full Text] [Related]
9. QT interval analysis in patients with chronic liver disease: a prospective study.
Kosar F; Ates F; Sahin I; Karincaoglu M; Yildirim B
Angiology; 2007; 58(2):218-24. PubMed ID: 17495272
[TBL] [Abstract][Full Text] [Related]
10. [Effects of cisapride on QT interval in children].
Tamariz-Martel Moreno A; Baño Rodrigo A; Sánchez Bayle M; Montero Luis C; Acuña Quirós MD; Cano Fernández J
Rev Esp Cardiol; 2004 Jan; 57(1):89-93. PubMed ID: 14746724
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the effects of cisapride on the QT interval and QT dispersion in chronic hemodialysis patients.
Mathis AS; Costeas C; Barone JA
Am J Kidney Dis; 2001 Dec; 38(6):1284-91. PubMed ID: 11728962
[TBL] [Abstract][Full Text] [Related]
12. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
Corović N; Duraković Z; Misigoj-Duraković M
Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
[TBL] [Abstract][Full Text] [Related]
13. Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation.
Zamirian M; Tavassoli M; Aghasadeghi K
Arch Iran Med; 2012 Jun; 15(6):375-7. PubMed ID: 22642249
[TBL] [Abstract][Full Text] [Related]
14. Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation.
Kim YK; Hwang GS; Shin WJ; Bang JY; Cho SK; Han SM
Transplant Proc; 2011 Jun; 43(5):1654-9. PubMed ID: 21693252
[TBL] [Abstract][Full Text] [Related]
15. [Clinical investigation of Q-T prolongation in hepatic cirrhosis].
Li L; Liu HR; Shu JL; Xi XP; Wang Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2717-8. PubMed ID: 18167253
[TBL] [Abstract][Full Text] [Related]
16. QT interval correction in patients with cirrhosis.
Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
[TBL] [Abstract][Full Text] [Related]
17. Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate.
Henriksen JH; Gülberg V; Fuglsang S; Schifter S; Bendtsen F; Gerbes AL; Møller S
Scand J Clin Lab Invest; 2007; 67(6):643-53. PubMed ID: 17852825
[TBL] [Abstract][Full Text] [Related]
18. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
19. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study.
Mumford JL; Wu K; Xia Y; Kwok R; Yang Z; Foster J; Sanders WE
Environ Health Perspect; 2007 May; 115(5):690-4. PubMed ID: 17520054
[TBL] [Abstract][Full Text] [Related]
20. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.
van Haarst AD; van 't Klooster GA; van Gerven JM; Schoemaker RC; van Oene JC; Burggraaf J; Coene MC; Cohen AF
Clin Pharmacol Ther; 1998 Nov; 64(5):542-6. PubMed ID: 9834046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
